Resistance patterns of non-small cell lung cancer treated with third-generation epidermal growth factor receptor-tyrosine kinase inhibitors
American Journal of Cancer Research · 2025 · 15 (6) · 2843-2854
DOI: 10.62347/anqd9699 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2025. Verfasst von Nana Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute Jinan, Shandong, China.
- Department of Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China.
- Department of Oncology, Dongying People's Hospital Dongying, Shandong, China.
- Department of Thoracic Surgery, Dongying People's Hospital Dongying, Shandong, China.
Zitieren
APA
Chen, N., Zhao, F., Yang, L., Tan, X., Wang, D., Ye, X., & Wei, Z. (2025). Resistance patterns of non-small cell lung cancer treated with third-generation epidermal growth factor receptor-tyrosine kinase inhibitors. American Journal of Cancer Research, 15(6), 2843-2854. https://doi.org/10.62347/anqd9699
Vancouver
Chen N, Zhao F, Yang L, Tan X, Wang D, Ye X, et al. Resistance patterns of non-small cell lung cancer treated with third-generation epidermal growth factor receptor-tyrosine kinase inhibitors. American Journal of Cancer Research. 2025;15(6):2843-2854. doi:10.62347/anqd9699
BibTeX
@article{Chen2025,
author = {Chen, Nana and Zhao, Feng and Yang, Lu and Tan, Xiaojing and Wang, Dongfeng and Ye, Xin and Wei, Zhigang},
title = {Resistance patterns of non-small cell lung cancer treated with third-generation epidermal growth factor receptor-tyrosine kinase inhibitors},
journal = {American Journal of Cancer Research},
year = {2025},
volume = {15},
number = {6},
pages = {2843--2854},
doi = {10.62347/anqd9699}
}
EUVIMED